Anita Y H Lee1, Derek L Chappell1, Monika J Bak2, Michael Judo3, Linda Liang3, Tatyana Churakova3, Gulesi Ayanoglu3, Jose Castro-Perez4, Haihong Zhou4, Stephen Previs4, Sandra C Souza4, Michael E Lassman5, Omar F Laterza1. 1. Translational Biomarkers, Merck Research Laboratories, Rahway, NJ; 2. NNF Center for Basic Metabolic Research, Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark; 3. Molecular Discovery, Antibody Generation Group and Assay Development, Immunoassay Group, Merck Research Laboratories, Palo Alto, CA; 4. Cardio-metabolic Disease Biomarkers, Merck Research Laboratories, Kenilworth, NJ. 5. Translational Biomarkers, Merck Research Laboratories, Rahway, NJ; michael_lassman@merck.com.
Abstract
BACKGROUND: Proglucagon-derived peptides (PGDPs), which include glucagon-like peptide (GLP)-1, glucagon, and oxyntomodulin, are key regulators of glucose homeostasis and satiety. These peptide hormones are typically measured with immuno-based assays (e.g., ELISA, RIA), which often suffer from issues of selectivity. METHODS: We developed a multiplexed assay for measuring PGDPs including GLP-1 (7-36) amide, GLP-1 (9-36) amide, glucagon, and oxyntomodulin by mass spectrometry and used this assay to examine the effect of a meal tolerance test on circulating concentrations of these hormones. Participants fasted overnight and were either given a meal (n = 8) or continued to fast (n = 4), with multiple blood collections over the course of 3 h. Plasma samples were analyzed by microflow immunoaffinity (IA)-LC-MS/MS with an isotope dilution strategy. RESULTS: Assay performance characteristics were examined and established during analytical validation for all peptides. Intra- and interassay imprecision were found to be 2.2%-10.7% and 6.8%-22.5%, respectively. Spike recovery was >76%, and dilution linearity was established up to a 16-fold dilution. Immediately after the meal tolerance test, GLP-1 and oxyntomodulin concentrations increased and had an almost identical temporal relationship, and glucagon concentrations increased with a slight delay. CONCLUSIONS: IA-LC-MS/MS was used for the simultaneous and selective measurement of PGDPs. This work includes the first indication of the physiological concentrations and modulation of oxyntomodulin after a meal.
BACKGROUND: Proglucagon-derived peptides (PGDPs), which include glucagon-like peptide (GLP)-1, glucagon, and oxyntomodulin, are key regulators of glucose homeostasis and satiety. These peptide hormones are typically measured with immuno-based assays (e.g., ELISA, RIA), which often suffer from issues of selectivity. METHODS: We developed a multiplexed assay for measuring PGDPs including GLP-1 (7-36) amide, GLP-1 (9-36) amide, glucagon, and oxyntomodulin by mass spectrometry and used this assay to examine the effect of a meal tolerance test on circulating concentrations of these hormones. Participants fasted overnight and were either given a meal (n = 8) or continued to fast (n = 4), with multiple blood collections over the course of 3 h. Plasma samples were analyzed by microflow immunoaffinity (IA)-LC-MS/MS with an isotope dilution strategy. RESULTS: Assay performance characteristics were examined and established during analytical validation for all peptides. Intra- and interassay imprecision were found to be 2.2%-10.7% and 6.8%-22.5%, respectively. Spike recovery was >76%, and dilution linearity was established up to a 16-fold dilution. Immediately after the meal tolerance test, GLP-1 and oxyntomodulin concentrations increased and had an almost identical temporal relationship, and glucagon concentrations increased with a slight delay. CONCLUSIONS: IA-LC-MS/MS was used for the simultaneous and selective measurement of PGDPs. This work includes the first indication of the physiological concentrations and modulation of oxyntomodulin after a meal.
Authors: Nicolai J Wewer Albrechtsen; Daniel Hornburg; Reidar Albrechtsen; Berit Svendsen; Signe Toräng; Sara L Jepsen; Rune E Kuhre; Marie Hansen; Charlotte Janus; Andrea Floyd; Asger Lund; Tina Vilsbøll; Filip K Knop; Henrik Vestergaard; Carolyn F Deacon; Felix Meissner; Matthias Mann; Jens J Holst; Bolette Hartmann Journal: EBioMedicine Date: 2016-03-31 Impact factor: 8.143
Authors: Duuamene Nyimanu; Richard G Kay; Rhoda E Kuc; Alastair J H Brown; Fiona M Gribble; Janet J Maguire; Anthony P Davenport Journal: Peptides Date: 2021-08-26 Impact factor: 3.750
Authors: Nicolai J Wewer Albrechtsen; Simon Veedfald; Astrid Plamboeck; Carolyn F Deacon; Bolette Hartmann; Filip K Knop; Tina Vilsboll; Jens J Holst Journal: J Diabetes Res Date: 2015-12-29 Impact factor: 4.011
Authors: Michele J Pachanski; Melissa E Kirkland; Daniel T Kosinski; Joel Mane; Boonlert Cheewatrakoolpong; Jiyan Xue; Daphne Szeto; Gail Forrest; Corin Miller; Michelle Bunzel; Christopher W Plummer; Harry R Chobanian; Michael W Miller; Sarah Souza; Brande S Thomas-Fowlkes; Aimie M Ogawa; Adam B Weinglass; Jerry Di Salvo; Xiaoyan Li; Yue Feng; Daniel A Tatosian; Andrew D Howard; Steven L Colletti; Maria E Trujillo Journal: PLoS One Date: 2017-10-20 Impact factor: 3.240
Authors: Peter Kirwan; Richard G Kay; Bas Brouwers; Vicente Herranz-Pérez; Magdalena Jura; Pierre Larraufie; Julie Jerber; Jason Pembroke; Theresa Bartels; Anne White; Fiona M Gribble; Frank Reimann; I Sadaf Farooqi; Stephen O'Rahilly; Florian T Merkle Journal: Mol Metab Date: 2018-08-21 Impact factor: 7.422
Authors: Jaimie Dufresne; Pete Bowden; Thanusi Thavarajah; Angelique Florentinus-Mefailoski; Zhuo Zhen Chen; Monika Tucholska; Tenzin Norzin; Margaret Truc Ho; Morla Phan; Nargiz Mohamed; Amir Ravandi; Eric Stanton; Arthur S Slutsky; Claudia C Dos Santos; Alexander Romaschin; John C Marshall; Christina Addison; Shawn Malone; Daren Heyland; Philip Scheltens; Joep Killestein; Charlotte E Teunissen; Eleftherios P Diamandis; K W Michael Siu; John G Marshall Journal: Clin Proteomics Date: 2018-12-21 Impact factor: 3.988
Authors: Francis S Willard; Jonathan D Douros; Maria Bn Gabe; Aaron D Showalter; David B Wainscott; Todd M Suter; Megan E Capozzi; Wijnand Jc van der Velden; Cynthia Stutsman; Guemalli R Cardona; Shweta Urva; Paul J Emmerson; Jens J Holst; David A D'Alessio; Matthew P Coghlan; Mette M Rosenkilde; Jonathan E Campbell; Kyle W Sloop Journal: JCI Insight Date: 2020-09-03